Table of Contents
1 Table Of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2
Pacemakers Pipeline Technology and Market Forecasts to 2015 7
2.1
Executive Summary 7
3 Pacemakers Technology Landscape 8
3.1
Pacemakers: Overview 8
3.2 Pacemakers: History 9
3.2.1 Pacemakers:
Clinical Trials 9
3.2.1.1 Mode Selection Trial (MOST) 9
3.2.1.2 Second
Canadian Trial of Physiologic Pacing (CTOPP II): Pilot Trial 10
4
Pacemakers Market Characterization 11
4.1 Pacemakers: Market Overview
11
4.1.1 Pacemakers: Revenue 11
4.1.2 Pacemakers: Volume 13
4.1.3
Pacemakers: Average Price 15
4.2 Pacemakers: Market Trends 16
4.2.1
Pacemakers: Market Drivers 16
4.2.1.1 Increasing Incidence of
Cardiovascular Diseases 16
4.2.1.2 Aging Population 16
4.2.1.3 Advent
of Advanced Pacemakers 16
4.2.1.4 Remote Monitoring Driving Pacemaker
Market 17
4.2.2 Pacemakers Market Restraints 17
4.2.2.1 Cost 17
4.2.2.2 Low Treatment Seeking Rate 17
4.2.2.3 Low Willingness to Use
17
4.2.2.4 Recalls 17
4.2.2.5 Reimbursement 17
4.2.2.6 CRT-Ds
Threat to Pacemakers 18
4.2.2.7 Lack of Skilled Surgeons 18
4.3
Pacemakers: Technology Trends 18
4.3.1.1 Wireless Pacemakers 18
4.3.1.2 MRI-safe Pacemakers 18
4.3.1.3 Human Embryonic Stem Cells as
Replacement of Electronic Pacemakers 18
4.3.1.4 Use of Pacemakers for
Other Indications 18
4.4 Pacemakers: Cross Country Analysis 20
4.5 Key
Takeaway 22
5 Pacemakers Competitive Landscape 23
5.1 Medtronic 23
5.2 St. Jude Medical 24
5.3 Boston Scientific 24
5.4 Others 24
5.5
Key Takeaway 24
6 Pacemakers Pipeline Products 25
6.1 Pacemakers
Pipeline Products by Development Stage 25
6.2 EnRhythm MRI SureScan Pacing
System 26
6.2.1 EnRhythm MRI SureScan Pacing System Product Status 26
6.2.2 EnRhythm MRI SureScan Pacing System Product Description 26
6.2.3
EnRhythm MRI SureScan Pacing System Clinical Trial One 27
6.2.4 EnRhythm
MRI SureScan Pacing System Clinical Trial Two 28
6.3 ESPRIT Pacemaker
29
6.3.1 ESPRIT Pacemaker Product Status 29
6.3.2 ESPRIT Pacemaker
Product Description 30
6.4 SJM MRI Pacing System 30
6.4.1 SJM MRI
Pacing System Product Status 30
6.4.2 SJM MRI Pacing System Product
Description 30
6.5 Global Pacemakers Pipeline Product Summary 31
6.6
Global Pacemakers Pipeline Product Clinical Trial Summary 31
6.7 Key
Takeaway 32
7 Appendix 33
7.1 Definitions 33
7.1.1 Pacemaker
33
7.1.1.1 Dual Chamber Pacemaker 33
7.1.1.2 Single Chamber Pacemaker
33
7.2 GlobalData Research Methodology 33
7.3 Coverage 34
7.4
Secondary Research 35
7.5 Primary Research 35
7.6 Models 36
7.7
Forecasts 36
7.8 Expert Panels 37
7.9 Contact Us 37
7.10
Disclaimer 37
1.1 List of Tables
Table 1: Pacemakers, Revenue ($
m), Global, 2000-2015 12
Table 2: Pacemakers, Revenue ($ m), Global,
2008-2015 12
Table 3: Pacemakers, Volume (Units), 2000-2008 14
Table
4: Pacemakers, Volume (Units), 2008-2015 14
Table 5: Comparison of Average
Prices in Top 12 Countries 15
Table 6: Disease and their Prevalence Rate
16
Table 7: Pacemakers Cross Country Analysis of Revenue, 2008 21
Table 8: Comparison of Revenue, Volume and Average Price of Pacemakers by
Region 22
Table 9: Revenue and Product Comparison of Top Three Companies
23
Table 10: EnRhythm MRI SureScan Pacing System, Product Status
26
Table 11: EnRhythm MRI SureScan Pacing System, Product Description
26
Table 12: EnRhythm MRI SureScan Pacing System - EnRhythm MRI
SureScan Pacing System Clinical Investigation 27
Table 13: EnRhythm
MRI SureScan Pacing System - MINimizE Right Ventricular Pacing To Prevent
Atrial Fibrillation And Heart Failure 28
Table 14: ESPRIT Pacemaker,
Product Status 29
Table 15: ESPRIT Pacemaker, Product Description
30
Table 16: SJM MRI Pacing System, Product Status 30
Table 17:
SJM MRI Pacing System, Product Description 30
Table 18: Global
Pacemakers Pipeline Product Summary 31
Table 19: Global Pacemakers
Pipeline Product Clinical Trial Summary 31
1.2 List of Figures
Figure 1: Types of Pacemakers 8
Figure 2: History of Pacemakers 9
Figure 3: Pacemakers, Revenue ($ m), Global, 2000-2015 11
Figure 4:
Pacemakers, Volume (Units), Global, 2000-2015 13
Figure 5: Pacemakers:
Driver-Restraint Analysis 19
Figure 6: Pacemakers Cross Country Analysis
of Revenue, 2008 20
Figure 7: Pipeline Products by Development Stage
25
Figure 8: GlobalData Methodology 34
| 
View Cart
